Strong Organic Revenue Growth
Fresenius Medical Care delivered a robust organic revenue growth of 7% with positive contributions from all three operating segments in the second quarter of 2025.
Significant Operating Income Growth
The company achieved a 13% increase in operating income, indicating strong margin expansion and effective cost management strategies.
Improved Cash Flow and Leverage
Operating cash flow increased by 75%, and the net leverage ratio improved to 2.7x, well within the target range of 2.5x to 3x.
Share Buyback Program Announcement
A EUR 1 billion share buyback program was announced, demonstrating confidence in future growth and commitment to shareholder returns.
Care Enablement Margin Progression
Care Enablement segment showed a significant 79% increase in operating income, advancing within the 2025 target margin band to 8.7%.
Value-Based Care Revenue Growth
Value-Based Care segment realized strong organic revenue growth of 28%, driven by expanded contracting and increased member months.